Report Detail

Request for Sample of this report

Pharma & Healthcare Global Iron Chelation Drug Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4654864
    • |
  • 05 December, 2025
    • |
  • Global
    • |
  • 141 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Iron Chelation Drug market size was valued at US$ 444 million in 2024 and is forecast to a readjusted size of USD 431 million by 2031 with a CAGR of -0.4% during review period.
In a healthy body, when the stores of iron are sufficient, the intestines reduce the absorption of this mineral from food and drink to prevent its levels from rising too high. People with iron overload disorders absorb more iron than usual from food or supplements. The body cannot excrete the extra iron fast enough, so it continues to build up. The body stores it in organ tissue, mainly in the liver, as well as the heart and the pancreas. There are several types of iron overload disorder. Hereditary hemochromatosis is a primary condition that has a genetic component. People can also have secondary hemochromatosis, which develops as a result of another disease or condition. The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely to benefit from chelation therapy include those with low or intermediate-1 IPSS risk MDS who have a long-life expectancy and are anticipated to receive more than 20 red blood cell transfusions and/or whose serum ferritin level is >1000 μg/L. Chelation therapy efficacy can be monitored by monitoring trends and levels of serum ferritin.
An iron chelation drug is a type of medication used to remove excess iron from the body. These drugs bind to the excess iron, forming a soluble complex that can be excreted from the body, primarily used in conditions like hemochromatosis and iron overload in patients receiving chronic blood transfusions. Common iron chelators include deferoxamine (Desferal), deferasirox (Exjade), and deferiprone (Ferriprox).
Global Iron Chelation Drug key players include Novartis, Chiesi Group, Sun Pharma, Cipla, Natco Pharma, etc. Global top five manufacturers hold a Revenue Market Share over 35%. Europe accounts for the most Sales Market Share, which have a share over 40%, followed by North America. In terms of product, Deferasirox is the largest segment, with a Revenue Market Share over 90%. And in terms of application, the largest Application is Transfusional Iron Overload, followed by NTDT Caused Iron Overload.
The primary driver of the iron chelation drug market is the increasing prevalence of diseases that cause iron overload, such as thalassemia, sickle cell anemia, and other chronic conditions requiring frequent blood transfusions. As awareness of iron overload and its complications grows, there is a greater demand for effective iron chelation therapies. Additionally, advancements in drug formulation and delivery methods, such as oral chelators, have improved patient compliance and convenience, further driving market growth.
One of the main challenges in the iron chelation drug market is the potential side effects and toxicity associated with chelation therapy. Adverse effects, such as gastrointestinal issues, kidney impairment, and hearing loss, can limit the long-term use of these drugs and affect patient adherence. Furthermore, the high cost of iron chelation therapy, especially newer oral formulations, can be a significant barrier for patients and healthcare systems, particularly in low- and middle-income countries.
This report is a detailed and comprehensive analysis for global Iron Chelation Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Iron Chelation Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Iron Chelation Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Iron Chelation Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Iron Chelation Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Iron Chelation Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Iron Chelation Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Chiesi Group, Sun Pharma, Cipla, Natco Pharma, Taro Pharm, Gland Pharma, Pfizer, Fresenius, Teva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Iron Chelation Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Deferasirox
Deferoxamine
Deferiprone
Market segment by Application
Transfusional Iron Overload
NTDT Caused Iron Overload
Major players covered
Novartis
Chiesi Group
Sun Pharma
Cipla
Natco Pharma
Taro Pharm
Gland Pharma
Pfizer
Fresenius
Teva
Alkem Laboratories
Alembic
Dr Reddy's Laboratories
Hikma Pharmaceuticals
Apotex
Viatris
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Iron Chelation Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Iron Chelation Drug, with price, sales quantity, revenue, and global market share of Iron Chelation Drug from 2020 to 2025.
Chapter 3, the Iron Chelation Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Iron Chelation Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Iron Chelation Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Iron Chelation Drug.
Chapter 14 and 15, to describe Iron Chelation Drug sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Iron Chelation Drug Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Deferasirox
    • 1.3.3 Deferoxamine
    • 1.3.4 Deferiprone
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Iron Chelation Drug Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Transfusional Iron Overload
    • 1.4.3 NTDT Caused Iron Overload
  • 1.5 Global Iron Chelation Drug Market Size & Forecast
    • 1.5.1 Global Iron Chelation Drug Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Iron Chelation Drug Sales Quantity (2020-2031)
    • 1.5.3 Global Iron Chelation Drug Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Novartis
    • 2.1.1 Novartis Details
    • 2.1.2 Novartis Major Business
    • 2.1.3 Novartis Iron Chelation Drug Product and Services
    • 2.1.4 Novartis Iron Chelation Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Novartis Recent Developments/Updates
  • 2.2 Chiesi Group
    • 2.2.1 Chiesi Group Details
    • 2.2.2 Chiesi Group Major Business
    • 2.2.3 Chiesi Group Iron Chelation Drug Product and Services
    • 2.2.4 Chiesi Group Iron Chelation Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Chiesi Group Recent Developments/Updates
  • 2.3 Sun Pharma
    • 2.3.1 Sun Pharma Details
    • 2.3.2 Sun Pharma Major Business
    • 2.3.3 Sun Pharma Iron Chelation Drug Product and Services
    • 2.3.4 Sun Pharma Iron Chelation Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Sun Pharma Recent Developments/Updates
  • 2.4 Cipla
    • 2.4.1 Cipla Details
    • 2.4.2 Cipla Major Business
    • 2.4.3 Cipla Iron Chelation Drug Product and Services
    • 2.4.4 Cipla Iron Chelation Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Cipla Recent Developments/Updates
  • 2.5 Natco Pharma
    • 2.5.1 Natco Pharma Details
    • 2.5.2 Natco Pharma Major Business
    • 2.5.3 Natco Pharma Iron Chelation Drug Product and Services
    • 2.5.4 Natco Pharma Iron Chelation Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Natco Pharma Recent Developments/Updates
  • 2.6 Taro Pharm
    • 2.6.1 Taro Pharm Details
    • 2.6.2 Taro Pharm Major Business
    • 2.6.3 Taro Pharm Iron Chelation Drug Product and Services
    • 2.6.4 Taro Pharm Iron Chelation Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Taro Pharm Recent Developments/Updates
  • 2.7 Gland Pharma
    • 2.7.1 Gland Pharma Details
    • 2.7.2 Gland Pharma Major Business
    • 2.7.3 Gland Pharma Iron Chelation Drug Product and Services
    • 2.7.4 Gland Pharma Iron Chelation Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Gland Pharma Recent Developments/Updates
  • 2.8 Pfizer
    • 2.8.1 Pfizer Details
    • 2.8.2 Pfizer Major Business
    • 2.8.3 Pfizer Iron Chelation Drug Product and Services
    • 2.8.4 Pfizer Iron Chelation Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Pfizer Recent Developments/Updates
  • 2.9 Fresenius
    • 2.9.1 Fresenius Details
    • 2.9.2 Fresenius Major Business
    • 2.9.3 Fresenius Iron Chelation Drug Product and Services
    • 2.9.4 Fresenius Iron Chelation Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Fresenius Recent Developments/Updates
  • 2.10 Teva
    • 2.10.1 Teva Details
    • 2.10.2 Teva Major Business
    • 2.10.3 Teva Iron Chelation Drug Product and Services
    • 2.10.4 Teva Iron Chelation Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Teva Recent Developments/Updates
  • 2.11 Alkem Laboratories
    • 2.11.1 Alkem Laboratories Details
    • 2.11.2 Alkem Laboratories Major Business
    • 2.11.3 Alkem Laboratories Iron Chelation Drug Product and Services
    • 2.11.4 Alkem Laboratories Iron Chelation Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Alkem Laboratories Recent Developments/Updates
  • 2.12 Alembic
    • 2.12.1 Alembic Details
    • 2.12.2 Alembic Major Business
    • 2.12.3 Alembic Iron Chelation Drug Product and Services
    • 2.12.4 Alembic Iron Chelation Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Alembic Recent Developments/Updates
  • 2.13 Dr Reddy's Laboratories
    • 2.13.1 Dr Reddy's Laboratories Details
    • 2.13.2 Dr Reddy's Laboratories Major Business
    • 2.13.3 Dr Reddy's Laboratories Iron Chelation Drug Product and Services
    • 2.13.4 Dr Reddy's Laboratories Iron Chelation Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Dr Reddy's Laboratories Recent Developments/Updates
  • 2.14 Hikma Pharmaceuticals
    • 2.14.1 Hikma Pharmaceuticals Details
    • 2.14.2 Hikma Pharmaceuticals Major Business
    • 2.14.3 Hikma Pharmaceuticals Iron Chelation Drug Product and Services
    • 2.14.4 Hikma Pharmaceuticals Iron Chelation Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Hikma Pharmaceuticals Recent Developments/Updates
  • 2.15 Apotex
    • 2.15.1 Apotex Details
    • 2.15.2 Apotex Major Business
    • 2.15.3 Apotex Iron Chelation Drug Product and Services
    • 2.15.4 Apotex Iron Chelation Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Apotex Recent Developments/Updates
  • 2.16 Viatris
    • 2.16.1 Viatris Details
    • 2.16.2 Viatris Major Business
    • 2.16.3 Viatris Iron Chelation Drug Product and Services
    • 2.16.4 Viatris Iron Chelation Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Viatris Recent Developments/Updates

3 Competitive Environment: Iron Chelation Drug by Manufacturer

  • 3.1 Global Iron Chelation Drug Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Iron Chelation Drug Revenue by Manufacturer (2020-2025)
  • 3.3 Global Iron Chelation Drug Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Iron Chelation Drug by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Iron Chelation Drug Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Iron Chelation Drug Manufacturer Market Share in 2024
  • 3.5 Iron Chelation Drug Market: Overall Company Footprint Analysis
    • 3.5.1 Iron Chelation Drug Market: Region Footprint
    • 3.5.2 Iron Chelation Drug Market: Company Product Type Footprint
    • 3.5.3 Iron Chelation Drug Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Iron Chelation Drug Market Size by Region
    • 4.1.1 Global Iron Chelation Drug Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Iron Chelation Drug Consumption Value by Region (2020-2031)
    • 4.1.3 Global Iron Chelation Drug Average Price by Region (2020-2031)
  • 4.2 North America Iron Chelation Drug Consumption Value (2020-2031)
  • 4.3 Europe Iron Chelation Drug Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Iron Chelation Drug Consumption Value (2020-2031)
  • 4.5 South America Iron Chelation Drug Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Iron Chelation Drug Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Iron Chelation Drug Sales Quantity by Type (2020-2031)
  • 5.2 Global Iron Chelation Drug Consumption Value by Type (2020-2031)
  • 5.3 Global Iron Chelation Drug Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Iron Chelation Drug Sales Quantity by Application (2020-2031)
  • 6.2 Global Iron Chelation Drug Consumption Value by Application (2020-2031)
  • 6.3 Global Iron Chelation Drug Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Iron Chelation Drug Sales Quantity by Type (2020-2031)
  • 7.2 North America Iron Chelation Drug Sales Quantity by Application (2020-2031)
  • 7.3 North America Iron Chelation Drug Market Size by Country
    • 7.3.1 North America Iron Chelation Drug Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Iron Chelation Drug Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Iron Chelation Drug Sales Quantity by Type (2020-2031)
  • 8.2 Europe Iron Chelation Drug Sales Quantity by Application (2020-2031)
  • 8.3 Europe Iron Chelation Drug Market Size by Country
    • 8.3.1 Europe Iron Chelation Drug Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Iron Chelation Drug Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Iron Chelation Drug Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Iron Chelation Drug Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Iron Chelation Drug Market Size by Region
    • 9.3.1 Asia-Pacific Iron Chelation Drug Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Iron Chelation Drug Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Iron Chelation Drug Sales Quantity by Type (2020-2031)
  • 10.2 South America Iron Chelation Drug Sales Quantity by Application (2020-2031)
  • 10.3 South America Iron Chelation Drug Market Size by Country
    • 10.3.1 South America Iron Chelation Drug Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Iron Chelation Drug Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Iron Chelation Drug Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Iron Chelation Drug Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Iron Chelation Drug Market Size by Country
    • 11.3.1 Middle East & Africa Iron Chelation Drug Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Iron Chelation Drug Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Iron Chelation Drug Market Drivers
  • 12.2 Iron Chelation Drug Market Restraints
  • 12.3 Iron Chelation Drug Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Iron Chelation Drug and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Iron Chelation Drug
  • 13.3 Iron Chelation Drug Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Iron Chelation Drug Typical Distributors
  • 14.3 Iron Chelation Drug Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Iron Chelation Drug. Industry analysis & Market Report on Iron Chelation Drug is a syndicated market report, published as Global Iron Chelation Drug Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Iron Chelation Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo